Venrock Healthcare Capital Partners logo

Venrock Healthcare Capital Partners

North America, California, United States, Palo Alto

Description

Venrock Healthcare Capital Partners is a fund dedicated to investing in publicly-held and privately-held healthcare companies.

Investor Profile

Venrock Healthcare Capital Partners has made 76 investments, with 15 in the past 12 months and 28% as lead.

Stage Focus

  • Post Ipo Equity (51%)
  • Series B (20%)
  • Series A (13%)
  • Series C (12%)
  • Undisclosed (1%)
  • Series D (1%)
  • Series E (1%)

Country Focus

  • United States (80%)
  • Canada (4%)
  • France (4%)
  • Switzerland (3%)
  • China (3%)
  • Ireland (3%)
  • Bermuda (1%)
  • Denmark (1%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Pharmaceutical
  • Medical
  • Biopharma
  • Life Science
  • Medical Device
  • Genetics
  • Oncology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Venrock Healthcare Capital Partners frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 16
Samsara BioCapital
North America, California, United States, Palo Alto
Co-Investments: 14
RTW Investments
North America, New York, United States, New York
Co-Investments: 17
TCG Crossover
North America, California, United States, Palo Alto
Co-Investments: 18
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 22
Fairmount Funds Management
North America, Pennsylvania, United States, Philadelphia
Co-Investments: 16
Perceptive Advisors
North America, New York, United States, New York
Co-Investments: 19
Logos Capital
North America, California, United States, San Francisco
Co-Investments: 20
Janus Henderson Investors
Europe, England, United Kingdom, London
Co-Investments: 15
Boxer Capital
North America, Florida, United States, Windermere
Co-Investments: 18

Which angels does Venrock Healthcare Capital Partners often collaborate with?

LW
North America, Washington, United States, Seattle
Shared Deals: 1
FB
North America, Ohio, United States, Columbus
Shared Deals: 1
BS
North America, Minnesota, United States, Minneapolis
Shared Deals: 1
SK
North America, California, United States, Los Angeles
Shared Deals: 1
Shared Deals: 1
RK
North America, California, United States, Los Angeles
Shared Deals: 1

What are some of recent deals done by Venrock Healthcare Capital Partners?

ORIC Pharmaceuticals

South San Francisco, California, United States

ORIC Pharmaceuticals is a biopharmaceutical company that develops treatments that target the causes of therapeutic resistance.

BiopharmaBiotechnologyHealth CarePharmaceuticalTherapeutics
Post Ipo EquityMay 28, 2025
Amount Raised: $125,000,000
CytomX Therapeutics

South San Francisco, California, United States

CytomX Therapeutics is a biotechnology company that focuses on developing proteolytically-activated antibodies.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Post Ipo EquityMay 12, 2025
Amount Raised: $100,000,000
AIRNA

Cambridge, Massachusetts, United States

AIRNA develops RNA editing technologies to create medicines for various diseases.

BiotechnologyHealth CareMedical
Series BApr 1, 2025
Amount Raised: $155,000,000
Surrozen

South San Francisco, California, United States

Surrozen is a biopharmaceutical that focuses on unlocking the body’s regenerative power to treat injury and disease.

BiotechnologyEmergency MedicineHealth Care
Post Ipo EquityMar 24, 2025
Amount Raised: $175,000,000
Solid Biosciences

Marlborough, Massachusetts, United States

Solid Biosciences is a life science company that conducts research for the treatment of Duchenne muscular dystrophy.

BiotechnologyGeneticsHealth CareMedical
Post Ipo EquityFeb 18, 2025
Amount Raised: $200,000,000
Timberlyne Therapeutics

San Diego, California, United States

Timberlyne Therapeutics is a biopharmaceutical company that develops therapies for autoimmune diseases.

BiopharmaBiotechnologyHealth Care
Series AJan 9, 2025
Amount Raised: $180,000,000
ADCendo

Copenhagen, Hovedstaden, Denmark

ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs.

BiotechnologyHealth Care
Series BNov 25, 2024
Amount Raised: $135,000,000
Cidara Therapeutics

San Diego, California, United States

Cidara Therapeutics is a biotechnology company that specializes in the fields of healthcare and therapeutics.

BiotechnologyHealth CareTherapeutics
Post Ipo EquityNov 21, 2024
Amount Raised: $105,000,000
Metsera

New York, New York, United States

Metsera is a biopharmaceutical company that develops medicines for obesity and metabolic diseases.

BiopharmaHealth CareMedicalPharmaceutical
Series BNov 13, 2024
Amount Raised: $215,000,000

Crescent Biopharma is a biotechnology firm focused on developing novel precision-engineered medicines.

BiotechnologyHealth CareMedical Device
UndisclosedOct 29, 2024
Amount Raised: $200,000,000